Skip to main content
GRDN logo

GRDN · Guardian Pharmacy Services, Inc. · Earnings Call Transcripts & Audio

Track GRDN — free
$40.78 +0.10 (+0.25%) At close · Sep 30
Market Cap
$2.61B
Shares
63.34M
Volume · Sep 30 540.21K Avg daily vol (3M) 477.5K

Guardian Pharmacy Services, Inc. Earnings Call Transcripts

Quarterly earnings calls for Guardian Pharmacy Services, Inc. (GRDN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Conference
Investor event
2026-09-15
Guardian Pharmacy Services, Inc. (GRDN) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-15
Guardian Pharmacy Services, Inc. (GRDN) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Guardian Pharmacy Services, Inc. (GRDN) Q2 2026 Earnings Call Transcript
Revenue
$351.77M
▲ 2.2% YoY
Gross margin
22.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript
Positive tone IRA transition and drug pricing impact Gross profit and EBITDA results M&A pipeline and national accounts
Revenue
$336.60M
▲ 2.2% YoY
Gross margin
22.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Guardian Pharmacy Services, Inc. (GRDN) Q4 2025 Earnings Call Transcript
Confident tone Inflation Reduction Act (IRA) Impact Vaccine Clinics Clinical Value and Interventions
Revenue
$397.62M*
▲ 17.4% YoY
Gross margin
21.5%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-10
Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript
Positive tone Acquisitions and Greenfields Margin Pressure from New Pharmacies Revenue and EBITDA Growth
Revenue
$377.43M
▲ 20% YoY
Gross margin
19.8%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Guardian Pharmacy Services, Inc. (GRDN) Q2 2025 Earnings Call Transcript
Confident tone Acquisitions and Greenfields Growth and Guidance Raise Margin Pressure from M&A Integration
Revenue
$344.33M
▲ 14.8% YoY
Gross margin
19.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Guardian Pharmacy Services, Inc. (GRDN) Q1 2025 Earnings Call Transcript
Confident tone Revenue and EBITDA Growth Acquisitions and Integration Tariff Impact Assessment
Revenue
$329.31M
▲ 19.6% YoY
Gross margin
19.5%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-26
Guardian Pharmacy Services, Inc. (GRDN) Q4 2024 Earnings Call Transcript
Confident tone Revenue and EBITDA growth M&A and greenfield expansion Inflation Reduction Act risk
Revenue
$338.57M*
Gross margin
19.8%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Guardian Pharmacy Services, Inc. (GRDN) Q3 2024 Earnings Call
Revenue
$314.39M
▲ 19.7% YoY
Gross margin
19.4%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–10 of 10 earnings calls
Key facts CIK 1802255 CUSIP 40145W101 13F (30d) 5 filings 5 filers Visit website Investor relations